Research • Reports • Resources
REPROCELL Advances iPSC Innovation with MSCRF Support
REPROCELL receives the Crystal Award for Innovation from MSCRF, recognizing its advancements in iPSC technology and regenerative medicine. Discover their latest achievements.
12 October 2026
Peripheral Blood Mononuclear Cells as Translational Tools in Drug Development
Explore the crucial role of Peripheral Blood Mononuclear Cells in drug development, enhancing immunotherapy, biomarker discovery, and personalized medicine.
01 October 2026
.jpg?width=1000&height=562&name=New%20Approach%20Methodologies%20(NAMs).jpg)
More Than Half a Century of Drug Development Attrition: Why Better Human-Relevant Models Are Needed
Explore the urgent need for human-relevant models in drug development to reduce high clinical attrition rates and improve patient outcomes.
03 September 2026
Scaling iPSC Manufacturing: From Cell Line Development to Clinical-Production
Learn how to scale iPSC manufacturing from clinical cell line development and gene editing to GMP cell banking and bioreactor expansion.
27 August 2026
Why PBMCs matter in gene and cell therapies
Explore the vital role of PBMCs in gene therapy and translational research, highlighting their importance in understanding immune responses and treatment efficacy.
23 July 2026
Why mRNA Reprogramming Is the Key to Safer and Faster iPSC Generation?
Discover how mRNA reprogramming enhances the safety, efficiency, and scalability of iPSC generation for therapeutic applications. Explore REPROCELL's innovative technologies and services.
How human fresh tissue models are helping RCD405 achieve regulatory approval
Discover how Arcede Pharma recently used human tissue testing to generate preclinical efficacy data for their compound RCD405.
How to isolate PBMCs from whole blood using density gradient centrifugation
Find out how to isolate PBMCs from whole blood samples using density gradient centrifugation a.k.a. the Ficoll Overlay method.
Streamlining PBMC Processing for Reliable Results in Multi-Site Clinical Trials: Key Challenges and Solutions
Explore the challenges and solutions in PBMC processing for multi-site clinical trials, ensuring reliable results and data integrity for research success.
.png?width=1280&height=720&name=hubspot_featured_image_1200x628%20(1).png)
AI-Designed CRISPR Enables Hypoimmune iPSC Engineering for Off-the-Shelf Cell Therapy
REPROCELL's StemEdit platform enables the creation of hypoimmune iPSCs for scalable off-the-shelf cell therapies, reducing immune rejection and enhancing patient access.
Looking to outsource your stem cell research project? Discover everything you need to know in our ultimate guide to REPROCELL’s stem cell research services
16 August 2021
Find out more about REPROCELL's neurite outgrowth assay that uses StemRNA Neuro cells.
20 March 2019
Subjects we write about